Bionime (TPE:4737) Cyclically Adjusted PB Ratio: (As of Aug. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:4737 Bionime Corp TPE:4737
67 GF Score
Price NT$57.40
GF Value NT$56.35
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Bionime Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Bionime  (TPE:4737) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Bionime Cyclically Adjusted PB Ratio Related Terms


Bionime Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Bionime's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionime Cyclically Adjusted PB Ratio Chart

Bionime Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.15 2.03 1.90 1.60 1.62

Bionime Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.76 1.69 1.62 1.85 0.00

TPE:4737 vs ISRG, BDX, MDLN: Cyclically Adjusted PB Ratio Comparison

For the Medical Instruments & Supplies subindustry, Bionime's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bionime Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bionime's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Bionime's Cyclically Adjusted PB Ratio falls into.


TPE:4737
67GF Score
Bionime Corp TPE:4737
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bionime Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Bionime's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Bionime's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=27.126/333.9520*333.9520
=27.126

Current CPI (Jun. 2026) = 333.9520.

Bionime Quarterly Data

Book Value per Share CPI Adj_Book
201609 35.674 241.428 49.346
201612 36.712 241.432 50.781
201703 35.043 243.801 48.001
201706 28.866 244.955 39.354
201709 31.792 246.819 43.015
201712 32.564 246.524 44.113
201803 32.838 249.554 43.944
201806 29.678 251.989 39.331
201809 30.153 252.439 39.889
201812 31.211 251.233 41.487
201903 31.439 254.202 41.302
201906 30.322 256.143 39.533
201909 30.486 256.759 39.651
201912 31.892 256.974 41.445
202003 32.003 258.115 41.406
202006 29.552 257.797 38.282
202009 30.376 260.280 38.974
202012 31.126 260.474 39.906
202103 31.416 264.877 39.609
202106 29.674 271.696 36.473
202109 30.185 274.310 36.748
202112 30.906 278.802 37.020
202203 29.472 287.504 34.233
202206 29.979 296.311 33.787
202209 30.328 296.808 34.123
202212 30.749 296.797 34.598
202303 28.814 301.836 31.880
202306 28.959 305.109 31.697
202309 28.924 307.789 31.383
202312 29.403 306.746 32.011
202403 28.168 312.332 30.118
202406 27.945 314.175 29.704
202409 27.159 315.301 28.766
202412 27.733 315.605 29.345
202503 27.769 319.799 28.998
202506 27.750 322.561 28.730
202509 27.244 324.800 28.012
202512 25.695 324.054 26.480
202603 28.487 330.213 28.810
202606 27.126 333.952 27.126

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Bionime (TPE:4737) Overvalued in 2026?

Based on GuruFocus' analysis, Bionime stock appears to be overvalued. The current stock price of NT$57.40 is trading 1.9% above its estimated GF Value™ of NT$56.35. GuruFocus considers Bionime to be Fairly Valued.

Key valuation signals for TPE:4737:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: NT$56.35 vs. price of NT$57.40 (1.9% above fair value)
  • GF Score™: 67/100 with 6 warning signs

No single metric tells the full story. See the TPE:4737 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bionime Business Description

Address No. 100, Daqing Street, Section 2, South District, Taichung, TWN, 40242
Bionime Corp is engaged in the manufacturing and selling of medical instruments, providing biotechnology services, examining pharmaceuticals, and selling precision instruments. The company's revenue is derived from the sale of blood glucose meters and test strips to domestic and foreign clients. Geographically, it operates in Algeria, China, Switzerland, the United States, Belarus, Egypt, the United Arab Emirates, and other countries, of which it derives the maximum revenue from Algeria.
67GF Score

Get the complete analysis for TPE:4737

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$57.40
Price
NT$56.35
GF Value